1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997; 89:3909–3918. PMID:
9166827.
2. Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res. 2005; 11:3349–3352. PMID:
15867234.
3. Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000; 95:802–806. PMID:
10648389.
Article
4. Tirelli A, Guastafierro S, Cava B, Lucivero G. Triclonal gammopathy in an extranodal non-Hodgkin lymphoma patient. Am J Hematol. 2003; 73:273–275. PMID:
12879432.
Article
5. Tursi A, Modeo ME. Monoclonal gammopathy of undetermined significance predisposing to
Helicobacter pylori-related gastric mucosa-associated lymphoid tissue lymphoma. J Clin Gastroenterol. 2002; 34:147–149. PMID:
11782609.
6. Yamasaki S, Matsushita H, Tanimura S, Nakatani T, Hara S, Endo Y, et al. B-cell lymphoma of mucosa-associated lymphoid tissue of the thymus: a report of two cases with a background of Sjögren's syndrome and monoclonal gammopathy. Hum Pathol. 1998; 29:1021–1024. PMID:
9744322.
7. Wöhrer S, Streubel B, Bartsch R, Chott A, Raderer M. Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res. 2004; 10:7179–7181. PMID:
15534090.
Article
8. Asatiani E, Cohen P, Ozdemirli M, Kessler CM, Mavromatis B, Cheson BD. Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement. Am J Hematol. 2004; 77:144–146. PMID:
15389912.
Article
9. Hwang EK, Jang EJ, Kim SM, Jeong SH, Lee HW, Kang SY, et al. A case report of Helicobacter pylori negative gastric MALT lymphoma with monoclonal gammopathy. Korean J Hematol. 2009; 44:261–267.
10. Ott MM, Rosenwald A, Katzenberger T, Dreyling M, Krumdiek AK, Kalla J, et al. Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities. Genes Chromosomes Cancer. 2000; 28:380–386. PMID:
10862046.
Article
11. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 2008. 4th ed. Lyon: International Agency for Research on Cancer;p. 214–216.
12. Deegan MJ, Abraham JP, Sawdyk M, Van Slyck EJ. High incidence of monoclonal proteins in the serum and urine of chronic lymphocytic leukemia patients. Blood. 1984; 64:1207–1211. PMID:
6437461.
Article
13. Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol. 1999; 36:148–154. PMID:
10319383.
14. Reitter S, Neumeister P, Beham-Schmid C, Emberger W, Strunk D, Brezinschek R, et al. A case of generalized MALT lymphoma with IgM paraproteinemia and peripheral blood involvement. Ann Hematol. 2010; 89:213–214. PMID:
19582453.
Article